Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Long

Showing results (921-930 of 1,523) with videos related to

Pageof 153
Sort By:
International Journal of Molecular Sciences|October 23, 2021
Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's DiseaseYi-Long Huang, Chao-Hsiung Lin, Tsung-Hsien Tsai, et al.
Future Oncology (London, England)|February 4, 2022
Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with <i>EGFR</i>m+ non-small-cell lung cancerJun Zhao, Hua Bai, Xin Wang, et al.
Journal of Hematology & Oncology|May 19, 2015
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation statusWenzhao Zhong, Xuening Yang, Honghong Yan, et al.
Cancer Management and Research|July 16, 2019
Familial association of lung cancer with liver cancer in first-degree relativesChong-Rui Xu, Huan Lin, Jian Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With <i>HER2</i> Alterations: A Phase Ia Dose-Escalation StudyJohn V Heymach, Frans Opdam, Minal Barve, et al.
International Immunopharmacology|February 11, 2025
ALPK1 signaling pathway activation by HMGB1 drives microglial pyroptosis and ferroptosis and brain injury after acute ischemic strokeOu Du, Ya-Ling Yan, Han-Yinan Yang, et al.
Journal of Cellular and Molecular Medicine|April 25, 2019
Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort studyYi Long Toh, Chia Jie Tan, Angie Hui Ling Yeo, et al.
Acta Pharmacologica Sinica|July 21, 2007
Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypesYun Yue, Ling Hu, Qin-jie Tian, et al.
Aging Cell|November 24, 2017
Comparative proteomic profiling reveals a role for Cisd2 in skeletal muscle agingYi-Long Huang, Zhao-Qing Shen, Chia-Yu Wu, et al.
International Journal of Environmental Research and Public Health|February 25, 2023
COVID-19 Related Early Google Search Behavior and Health Communication in the United States: Panel Data Analysis on Health MeasuresBinhui Wang, Beiting Liang, Qiuyi Chen, et al.
Pageof 153

Showing results (921-930 of 1,523) with videos related to

Sort By:
Pageof 153
International Journal of Molecular Sciences|October 23, 2021
Discovery of a Metabolic Signature Predisposing High Risk Patients with Mild Cognitive Impairment to Converting to Alzheimer's DiseaseYi-Long Huang, Chao-Hsiung Lin, Tsung-Hsien Tsai, et al.
Future Oncology (London, England)|February 4, 2022
Biomarker subset analysis of a phase IIIb, open-label study of afatinib in EGFR tyrosine kinase inhibitor-naive patients with <i>EGFR</i>m+ non-small-cell lung cancerJun Zhao, Hua Bai, Xin Wang, et al.
Journal of Hematology & Oncology|May 19, 2015
Phase II study of biomarker-guided neoadjuvant treatment strategy for IIIA-N2 non-small cell lung cancer based on epidermal growth factor receptor mutation statusWenzhao Zhong, Xuening Yang, Honghong Yan, et al.
Cancer Management and Research|July 16, 2019
Familial association of lung cancer with liver cancer in first-degree relativesChong-Rui Xu, Huan Lin, Jian Su, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2025
HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With <i>HER2</i> Alterations: A Phase Ia Dose-Escalation StudyJohn V Heymach, Frans Opdam, Minal Barve, et al.
International Immunopharmacology|February 11, 2025
ALPK1 signaling pathway activation by HMGB1 drives microglial pyroptosis and ferroptosis and brain injury after acute ischemic strokeOu Du, Ya-Ling Yan, Han-Yinan Yang, et al.
Journal of Cellular and Molecular Medicine|April 25, 2019
Association of plasma leptin, pro-inflammatory adipokines and cancer-related fatigue in early-stage breast cancer patients: A prospective cohort studyYi Long Toh, Chia Jie Tan, Angie Hui Ling Yeo, et al.
Acta Pharmacologica Sinica|July 21, 2007
Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypesYun Yue, Ling Hu, Qin-jie Tian, et al.
Aging Cell|November 24, 2017
Comparative proteomic profiling reveals a role for Cisd2 in skeletal muscle agingYi-Long Huang, Zhao-Qing Shen, Chia-Yu Wu, et al.
International Journal of Environmental Research and Public Health|February 25, 2023
COVID-19 Related Early Google Search Behavior and Health Communication in the United States: Panel Data Analysis on Health MeasuresBinhui Wang, Beiting Liang, Qiuyi Chen, et al.
Pageof 153